P Pu ur rp po os se e: : To describe changes to the conduct of withdrawal of life support (WOLS) in two teaching hospital tertiary care medical surgical intensive care units (ICUs) in a single centre over two distinct time periods.
C Co on nc cl lu us si io on n: : Simple changes to the process of WOLS can improve conduct of end-of-life care in the ICU.
Objectif : Décrire les changements apportés au retrait du maintien des fonctions vitales (RMFV) dans deux unités de soins intensifs (USI) médicaux et chirurgicaux d'un centre hospitalier universitaire de soins tertiaires au cours de deux périodes distinctes.

Méthode : Nous avons utilisé une revue rétrospective des dossiers et réalisé une comparaison du type avant-après. Nous avons évalué les différents aspects des soins aux mourants de l'USI, décédés après le RMFV, avant et après l'introduction d'instruments clarifiant l'ordonnance de ne pas réanimer (PDR) et normalisant le processus de RMFV. Nous avons recueilli les suggestions de la famille sur les soins aux mourants et modifié les ordonnances des médecins sur l'analgésie et la sédation.
Résultats : Cent trente-huit patients sont décédés après le RMFV dans les USI entre juillet 1996 et juin 1997 (PRE) et 168 après un RMFV entre mai 1998 et avril 1999 (POST). L'intervalle entre l'admission à l'USI et le RMFV (moyenne ± écart type) a été plus court dans la période POST (191 ± 260 h PRE vs 135 ± 205 h POST, P = 0,05). Moins de patients du groupe POST ont reçu une réanimation cardiopulmonaire dans les 12 h précédant la mort (PRE = 7 ; POST = 0 : P < 0,05). Moins de médicaments de confort ont été utilisés (PRE : 1,7 ± 1,0 vs POST : 1,4 ± 1,0 ; P < 0,05). La dose cumulative moyenne de diazépam (PRE : 20,0 vs POST : 10,0 mg ; P < 0,05) a diminué. La participation des médecins aux discussions sur le RMFV n'a pas changé mais les interventions du service de pastorale ont augmenté (PRE : 10/138 vs POST : 120/168 cas ; P < 0,05). La majorité des infirmières (80 %) croyaient que les ordonnances modifiées de PDR et de RMFV ont permis d'améliorer le traitement entourant le RMFV.
Conclusion : Des changements simples au processus de RMFV peuvent améliorer les soins aux mourants dans une USI.
HE landmark study to understand prognoses and preferences for outcomes and risks of treatment (SUPPORT) demonstrated that many patients at the end-of-life receive care incongruent with their wishes. 1 Subsequently there have been many calls for better defined goals for, and better care of, dying patients in the intensive care units (ICUs). [2] [3] [4] [5] [6] [7] Improvements to care in the ICU could take many forms: attention to communication strategies, better understanding of cultural issues, use of ethical committees in difficult cases or process issues within the ICU to improve consistency in care delivery. Regarding consistency, we recently reported tenfold variations in prescribed doses of morphine during the last 12 hr of life in dying ICU patients. 8 Others have reported variability in other aspects of end-of-life care e.g., the frequency; [9] [10] [11] the manner; 7, [12] [13] [14] and the biases that individual physicians bring to the process of life support withdrawal. [15] [16] [17] [18] [19] Practice variation does not best serve the needs of patients or those responsible for managing them during the dying process. Understanding practice variation and addressing concerns over suboptimal process issues within an ICU are bases for introducing change.
The purpose of this report is to describe changes to the conduct of withdrawal of life support (WOLS) in two teaching hospital tertiary care medical surgical ICUs in a single centre.
M Ma at te er ri ia al ls s a an nd d m me et th ho od ds s We compared aspects of end-of-life care in two phases in the two closed, academic adult medical/surgical ICUs (24 beds in total) at the Queen Elizabeth II Health Sciences Centre (QEII HSC, 826 beds), the only acute care medical centre for Halifax, Nova Scotia, (catchment population 250,000). It is a tertiary/quaternary care referral centre for the Atlantic Canadian provinces.
Phase I (PRE)
Following legal action against one of our colleagues after a WOLS [a first degree murder charge (later dismissed)], 20, 21 we reviewed care of all patients dying in the ICU from July 1996 to June 1997. The results of this review are reported in detail elsewhere. 8 In brief, we described the use of technological support, variability in physician documentation of end-of-life discussions, and use of medication in the last 12 hr of life in 174 dying patients of whom 36 died despite active support and 138 after life support was forgone. During this time period, ten intensivists cared for patients in the ICU, providing 24 hr coverage and rotating on a weekly basis.
Interventions
After phase I we discussed the practice review 8 with ICU nurses and physicians at all levels (usually in small group focus sessions) and ensured that all members of staff had the opportunity to attend sessions to discuss end-of-life care. Three initiatives were then implemented: 1) concerns regarding end-of-life care were solicited from the ICU nursing staff and from ten families of patients who died in the ICU, by requesting written feedback. To address issues raised, instruments were developed and refined (see below under instrument development and also Appendices A and B, available as Additional Material at www.cja-jca.org); 2) nursing progress note entries were altered to reflect more complete documentation of dyspnea, pain, agitation and their management; 3) use of open-ended orders (i.e., no fixed upper limit to amount of drug which could be administered) was proscribed. These initiatives were implemented between July 1997 and December 1997.
Contacting families and instrument development
To elicit concerns of families before any intervention, one of us (D.M.) conducted telephone interviews with next-of-kin of ten patients who had died in the ICU, at least six months after death. Issues identified during a semi-structured interview included: insufficient involvement of members from the religious community; perceptions of pain and discomfort during the dying process and communication between staff physicians and others involved in the care of the ICU patient, particularly as WOLS was discussed and implemented. To address these issues we included specific items and procedures in the WOLS instrument (Appendix A). Feedback from another ten patients who survived the ICU and family members of 20 patients who died enabled us to refine our interventions and instruments.
Feedback from nurses
Nurses wanted more involvement in discussions with families about WOLS, appropriate documentation, and timely discontinuation of technical interventions (e.g., dialysis) when a decision was made to withdraw life support. A do not resuscitate (DNR) order instrument (Appendix B) reflected the need for timely discussion and clarification of intentions of a DNR order. Nurses also expressed concern over the numbers and amounts of drugs for comfort before physician notification was required. Moreover, the results of an internal scenario-based survey received from eight of eight intensivists and from 75 of 144 nurses indicated major differences in prescribing habits for physicians and nursing interpretation of physicians' open-ended orders. This finding led to a policy of no 'open-ended' physician orders. We also modified the nursing policy and progress notes to require documentation and allow adjustment of comfort medication based on patient-specific targeted sedation and analgesic levels.
Educational development
A core group of staff nurses from the participating ICUs met with other staff to discuss issues surrounding improvement of end-of-life care. The investigators met monthly to develop and refine the instruments, and one of us (D.M.) liased each month with the core group of staff nurses to make alterations to nursing notes, and provide education on symptom management including medication during the WOLS process.
Phase II (POST)
The medical records of patients dying in the ICU between May 1998 and April 1999 were reviewed and data were abstracted.
Definitions
We used the following definitions: Forgoing (withholding/withdrawing) life support -removal or no further addition or escalation of major life support modalities including inotropes, mechanical ventilation, dialysis etc., with the recognition that this would likely result in the patient's death from the underlying medical condition. We did not distinguish between withholding or WOLS. Comfort measures -the administration of drugs such as narcotics and sedatives to prevent symptomatic discomfort occurring during the dying process.
Data abstraction
Information was collected by two reviewers (R.H. and D.M.) to maintain consistency. Any discrepancies were adjudicated and resolved by consensus. We recorded: patient age; gender; reason for ICU admission; whether admitted from a medical or surgical service; date of hospital admission; date of ICU admission; ICU admission diagnosis; admission APACHE II score; 22 date and time of death; cause of death; hospital length of stay; ICU length of stay; attending intensivist at the time of death; date and time at which a decision was made to forgo life support; mechanical ventilatory status at time of death; whether life support was forgone and, if so, date and time; time from forgoing of life support to death. Treatments received in the final 12 hr of life refers to: mechanical ventilation; dialysis; nutritional support; changes to the inspired oxygen fraction (FIO 2 ) and all medication use. Life support related discussions refers to: documented plans to forgo life support by staff intensivists and/or other physicians anywhere in the medical record and/or written evidence of involvement of pastoral care services for family support.
Data analysis
For demographic variables, categorical data were analyzed using Chi square or Fisher's exact test, and continuous data were analyzed by t test or ANOVA. Differences in hourly drug dose over time were analyzed by Kruskal-Wallis test for repeated measurements. We used the Mann Whitney U test to determine differences in median cumulative dose of medication. Differences between groups for use of life support measures and incidence of documentation of discussions were compared using a Chi square analysis. Differences were accepted as statistically significant when P < 0.05 (Systat® v 10.0 statistical software (SPSS Inc., Chicago, IL, USA). Unless otherwise indicated, data results are expressed as mean (± SD) or as median (range).
R Re es su ul lt ts s Demographics During the POST period, there were 1,660 ICU admissions and 209 deaths (13%). Life support was forgone for 168 patients (80%). These figures are similar to those in the PRE period, with a 13% mortality and an incidence of forgoing life support of 79%. 8 We describe demographic data and the ICU course for the patients in Table I . Patients in the POST group were younger and time from ICU admission to WOLS was shorter in the POST period. Once life support was forgone, time to death was similar in both groups. Hospital length of stay (but not ICU length of stay) was longer PRE vs POST. In the PRE group, a greater proportion of patients died from pneumonia (21/138 vs 12/168; P < 0.05), intra-abdominal sepsis (22/138 vs 7/168; P < 0.05) and fewer died from trauma (0/138 vs 12/168; P < 0.05) or neurological insult (17/138 vs 50/168; P < 0.05). Otherwise all other causes of death were similar in the two phases (data not shown).
Treatments forgone
There was a trend toward a reduction in the provision of nutritional support in the POST group (Table II) . More patients in the PRE group had received cardiopulmonary resuscitation (CPR) (PRE = 7 vs POST = 0; P < 0.05) in the 12-hr interval prior to death. The number of patients receiving dialysis in this 12-hr period was similar (PRE = 2 vs POST = 4). No patient in either group received CPR or dialysis once the decision to forgo life support was made.
Use of comfort medication
We noted a reduction in the number of comfort medications administered per patient (1.7 ± 1.0 vs 1.4 ± 1.0; P = 0.005). We noted a significant reduction in the cumulative median dose of diazepam administered for comfort in the POST group (Table III) , although morphine dosing was unchanged.
Documentation of the life support withdrawal process
Documentation by physicians of life support related discussions was similar in the PRE (120/138) vs POST (148/168) periods. Documented involvement of pastoral care in the support of families of dying patients increased (ten cases noted PRE vs 120 cases POST; P < 0.05). When combined, documentation of WOLS discussions by some members of the health care team occurred in 135/138 cases PRE vs 161/168 cases POST.
Staff satisfaction
A majority (65%) of 45 staff nurses responding to an internal utilization survey of our checklists were comfortable using them and felt that an improvement had occurred in the process of life support withdrawal. In particular, ~ 80% of nurses felt the DNR checklist had resulted in much clearer physician orders and the WOLS checklist in a more consistent process. Most nurses felt that the development of checklists and objective scoring systems (for pain, sedation and dyspnea) had improved patient care at the end-of-life. D Di is sc cu us ss si io on n In this single institution review of end-of-life care in an ICU, implementation of some simple initiatives improved our process of WOLS. These initiatives, based on a practice review and feedback from families and staff, included an aide memoire (Appendix A) to be used during the WOLS process and a checklist to clarify levels of care (Appendix B). We focused on earlier discussions of goals of care. This resulted in less frequent CPR prior to decisions to forgo life support, a reduction in the time from admission to the ICU to the institution of WOLS when death was inevitable, and increased attention to spiritual needs as life approached its end.
We noted a reduction in the number of comfort medications employed at the end-of-life suggesting less variability in drug prescriptions. Establishing upper limits for drugs at a specified time required (n = 142)*** PRE = prior to introduction of end-of-life care initiatives; POST = following introduction of end-of-life initiatives; CI = confidence interval. *Yes = treatment forgone; **No = treatment continued until death occurred; ***For whom data was available. more dialogue between the bedside nurse and attending physician and required the attending physician to more closely supervise the dying process. We accept that earlier adverse publicity surrounding legal charges against a colleague may have resulted in more conservative prescriptions for some comfort medications but similar usage of morphine and comparison of individual practices suggested that this was not the case. In specific circumstances physicians used high doses of comfort medications when required as reflected in the range of doses for medications in Table III . Moreover, some physicians in the POST group had not been part of the cohort of intensivists scrutinized during the legal proceedings. We also recognize that the higher proportion of patients with identified neurological comorbidities may have limited the doses of medications prescribed. The increased proportion of patients with neurological co-morbidities likely reflects the incorporation of neurosurgical patients into the case mix occurring primarily in the POST period as a result of regional health care reorganization rather than any change in other demography.
Documentation of discussions surrounding end-oflife issues was high PRE and POST with little room for improvement. We firmly believe that failure of clear documentation of such discussions is as difficult to justify at the end-of-life as it is when the initial focus is curative.
Strengths of our practice review include the fact that participating physicians, including the authors, were unaware that any comparison of practice would be made at the time that these events occurred. The retrospective nature of this study avoided any inherent biases in this regard. The similar admission APACHE II score and the similar rate with which life support was forgone suggest the two groups, as defined, were suitable for comparison although we accept there was an increased incidence of central nervous system related co-morbidities, a reduced incidence of death from pneumonia and sepsis in the PRE period, and more trauma patients in the POST period. We sought to characterize and improve processes following the decision to forgo life support. We established a baseline by examining a retrospective review of a cohort of patients dying prior to introduction of our changes. We surveyed our staff and the families of patients dying in the ICU to determine any perceived deficiencies in the provision of end-of-life care, including the process of forgoing of life support, and introduced initiatives to address these issues. Finally, after an appropriate time to allow the 'novelty' of the changes to wear off (July 1997 to April 1998), we determined whether we had made any noteworthy changes in our end-of-life care.
Our results suggest some improvements have occurred. There is robust evidence that multi-method initiatives such as this can change behaviour. 23 We used five effective behaviour change strategies: 1) audit; 2) feedback about the audit results; 3) reminders to all ICU clinicians (e.g., the WOLS checklist); 4) use of protocols; 5) involvement of the investigators as committed local opinion leaders.
Our practice review has several important limitations. We recognize the deficiencies of a retrospective review and accept that a randomized controlled trial of our interventions would have been preferable. Our study was conducted in one institution and results might not be generalizable to other centres, but the improvement initiatives were simple and, we believe, could be repeated elsewhere. We recognize that the number of families surveyed was small and this limits validity of any statistical analysis of their responses. In addition we did not conduct a PRE and POST analysis of staff or family satisfaction. The degree to which ongoing legal action influenced behaviour in the early portion of the POST period should not be discounted. However, we believe that this factor likely diminished with time. We were unable to assess compliance with the instruments developed but the adoption of the instruments both in our institution and by others [see under ICU policies (3.ICU order forms) at www.promotingexcellence.org/navigate/critical_care _bib.html] is, we believe, an indication of positive changes in approach to end-of-life care in ICUs.
In summary, quality improvement initiatives similar to ours have the potential to positively address concerns expressed by patients, families and health care teams in the ICU. The identification of areas of concern requires a commitment to effective communication both within and between ICU health care teams and patients and families in the ICU.
A Ac ck kn no ow wl le ed dg ge em me en nt ts s We thank our patients and families, the ICU nursing and medical staff, and the Institute for Health Care Improvement for providing us with the inspiration to try to improve end-of-life care in our ICUs. 
